Catalyst
Slingshot members are tracking this event:
Novartis (NVS) Announces Plans for Phase 2 Trial Assessing MorphoSys Ag's (MPSYF) Bimagrumab in Obese Patients with Type 2 Diabetes
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 12, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Bimagrumab, Obese Patients, Type 2 Diabetes
